Apotex Corp. 2023-03-15 Health serious FDA
Health · FDA · Recall #FDA-D-0433-2023
Brimonidine Tartrate Ophthalmic Solution 0.15%, Rx Only, Packaged as: a) 5 mL dropper… Recall
Issued March 15, 2023 · Apotex Corp.
In March 2023, Apotex Corp. recalled the Brimonidine Tartrate Ophthalmic Solution 0.15%, Rx Only, Packaged as: a) 5 mL dropper…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of sterility assurance: Cracks have developed in some of the units caps of Brimonidine tartrate ophthalmic solution bottles. There is a possibility the broken cap may impact sterility.
What you should do
- 1 Stop using Brimonidine Tartrate Ophthalmic Solution 0.15%, Rx Only, Packaged as: a) 5 mL dropper… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Apotex Corp. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Apotex Corp.
- Category
- Health
- Recall date
- March 15, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0433-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Apotex Corp. has 9 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.